Category Archives: Organizations

Poor countries allowed to import generic drugs – WTO

By Tom Miles, Reuters | January 23, 2017 Poor countries are allowed to import generic medicines, World Trade Organization (WTO) Director General Roberto Azevedo told Reuters on Monday, after the required two-thirds of members agreed a deal that has taken … Continue reading

Posted in Generics, TRIPS, Uncategorized, WTO | Leave a comment

It’s Official: TRIPS Health Amendment In Effect, First Ever To A WTO Agreement

Source: http://www.ip-watch.org More than a decade after World Trade Organization member states approved the first-ever legal amendment to a WTO agreement, the change to the international intellectual property agreement has entered into effect. Five more members ratified the amendment in … Continue reading

Posted in Compulsory Licensing, Doha Declaration, TRIPS, TRIPS flexibilities, Uncategorized, WTO | Leave a comment

New Book Highlights IP Trade Law Flexibilities For Public Health

Source: http://www.ip-watch.org A recently published book by a high-impact public health advocate provides new analysis on the use of flexibilities in international trade law relating to intellectual property rights aimed at advancing discussions on solutions to high drug prices worldwide. … Continue reading

Posted in IPR, TRIPS, TRIPS flexibilities, Uncategorized, WTO | Leave a comment

India at WTO: Takes strong stand to save generic drugs industry, calls for transparent health assessment

By Shreerupa Mitra-Jha, FirstPost | November 13, 2016 Governments engaged in bilateral and regional trade investments should ensure that these agreements do not include provisions that impinge on the right to health, and as a first step should undertake public health … Continue reading

Posted in TRIPS, TRIPS flexibilities, TRIPS plus, Uncategorized, UNHLP report, WHO | Leave a comment

The U.S. Is Standing in the Way of Cheaper Drugs for the Poor

By JASON CONE and RAYMOND C. OFFENHEISER, The New York Times|OCT. 27, 2016 Every few months, a drug company gets caught cranking up prices. Most recently, Mylan, the maker of EpiPen, took its turn in the hot seat for raising the … Continue reading

Posted in Innovation, R&D, TPP, Uncategorized, UNHLP report, WHO | Leave a comment

India Seeks Protection With New Model Bilateral Investment Treaty

By Prabhas Ranjan, The Wire| February 2, 2016 Pricked after being sued by foreign investors under different bilateral investment treaties (BIT), India has adopted a new model. But it could impact the ongoing India-US BIT negotiations. Provoked by foreign investors suing India … Continue reading

Posted in BITS, Compulsory Licensing, TRIPS, Uncategorized, WTO | Leave a comment

Six Indian pharma companies get new licences to supply generic drugs

By Shreerupa Mitra-Jha, Firstpost | July 8, 2016 The UN-backed Medicines Patent Pool (MPP) announced on 7 July new generic manufacturing licensing, for antiretrovirals (ARVs) and direct acting anti-viral (DAA) for treating hepatitis C, with seven pharmaceutical companies, six of … Continue reading

Posted in Generics, Hepatitis C, Medicine Patent Pool, Uncategorized | Leave a comment